# OMB Seeks Domestic Medicine Manufacturing Input

The Office of Management and Budget (OMB) is seeking information from qualified pharmaceutical, chemical, and petrochemical manufacturers on domestic and near-shore production of essential medicines, including medicines on the Administration for Strategic Preparedness and Response’s (ASPR) 86 List. The RFI is intended to inform federal planning to strengthen U.S. supply and reduce reliance on foreign sources; the comment period closes November 27, 2026, **22 days from November 5**.

- Manufacturers with relevant production capabilities can submit information by November 27 to inform agencies’ supply-chain planning; this is an RFI, not a contract solicitation or award.
- Pharmaceutical, chemical, and petrochemical firms should review the RFI’s scope, including the ASPR 86 List, and provide relevant information on domestic or near-shore manufacturing capabilities.
- Will Purcell at the SBA Office of Advocacy is identified as the RFI contact: will.purcell@sba.gov.

**Jurisdictions:** federal
**Industries:** Healthcare
**Published:** November 04, 2026

### Government Entities
- Office of Management and Budget (OMB)
- U.S. Small Business Administration Office of Advocacy (SBA)
- Administration for Strategic Preparedness and Response (ASPR)

### Sources
- [OMB Requests Information on Domestic and Near Shore Manufacturing of Essential Medicines – Office of Advocacy](https://advocacy.sba.gov/2026/11/04/omb-requests-information-on-domestic-and-near-shore-manufacturing-of-essential-medicines) - Office of Advocacy (.gov)